108 related articles for article (PubMed ID: 37005955)
1. Transcriptional adaptor 3 influences the proliferative and invasive phenotypes of non-small cell lung cancer cells via regulating EMT.
Xu LQ; Zhang SW; Zhang R; Chen JJ; Yuan ZX; Feng J; Huang JA
Neoplasma; 2023 Apr; 70(2):240-250. PubMed ID: 37005955
[TBL] [Abstract][Full Text] [Related]
2. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
3. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
Pang L; Cheng Y; Zou S; Song J
Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
[TBL] [Abstract][Full Text] [Related]
6. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition.
Liao J; Dong LP
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3829-3837. PubMed ID: 31115010
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
8. High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.
Li N; Xu L; Zhang J; Liu Y
Int J Exp Pathol; 2022 Jun; 103(3):90-101. PubMed ID: 35366027
[TBL] [Abstract][Full Text] [Related]
9. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer.
Yang F; Shao C; Wei K; Jing X; Qin Z; Shi Y; Shu Y; Shen H
J Cell Physiol; 2019 Dec; 234(12):23596-23607. PubMed ID: 31236953
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR-370-3p/SNAIL axis by inducing cell epithelial-mesenchymal transition (EMT).
Long X; Wang DG; Wu ZB; Liao ZM; Xu JJ
Cancer Med; 2023 Apr; 12(7):8289-8305. PubMed ID: 36530171
[TBL] [Abstract][Full Text] [Related]
11. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
Li WQ; Zhang JP; Wang YY; Li XZ; Sun L
Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561
[TBL] [Abstract][Full Text] [Related]
13. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.
Wei S; Zheng Y; Jiang Y; Li X; Geng J; Shen Y; Li Q; Wang X; Zhao C; Chen Y; Qian Z; Zhou J; Li W
EBioMedicine; 2019 Jun; 44():182-193. PubMed ID: 31160270
[TBL] [Abstract][Full Text] [Related]
14. miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction.
Zhang Y; Yuan J; Guo M; Xiang R; Wang X; Xie T; Zhuang X; Li Q; Lai Q
Dis Markers; 2022; 2022():4842454. PubMed ID: 36033827
[TBL] [Abstract][Full Text] [Related]
15. Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug.
Khan P; Manna A; Saha S; Mohanty S; Mukherjee S; Mazumdar M; Guha D; Das T
BMC Cancer; 2016 Jan; 16():39. PubMed ID: 26810856
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer.
Dai HY; Ma Y; Da Z; Hou XM
Pathol Res Pract; 2018 Aug; 214(8):1130-1135. PubMed ID: 29929749
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
Kumarswamy R; Mudduluru G; Ceppi P; Muppala S; Kozlowski M; Niklinski J; Papotti M; Allgayer H
Int J Cancer; 2012 May; 130(9):2044-53. PubMed ID: 21633953
[TBL] [Abstract][Full Text] [Related]
18. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
Chen W; Zhang Y; Fang Z; Qi W; Xu Y
Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
[TBL] [Abstract][Full Text] [Related]
19. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
[TBL] [Abstract][Full Text] [Related]
20. Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis.
Jin D; Guo J; Wu Y; Chen W; Du J; Yang L; Wang X; Gong K; Dai J; Miao S; Li X; Su G
J Exp Clin Cancer Res; 2020 Jan; 39(1):6. PubMed ID: 31906986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
